The Benefits of Individualized Follow-up With a Sport-Health Professional in the Care of Patients With Chronic Respiratory Diseases
Condition(s) studied
Investigational drug(s) / intervention(s)
Personalized follow-up and support: After a pulmonary rehabilitation program, an interview with a professional will enable the professional to identify the barriersand enablers of physical activity engagement, and to identify (with the patient) a plan for maintaining a physical activities adapted in daily life. Adapted solutions will then be proposed.
Study summary
Pulmonary rehabilitation is an integral part of care for patients with chronic respiratory diseases. It improves patients' physical capacities, quality of life and symptoms, at least in the short term.
The hypothesis that patients receiving personalized support from a professional following pulmonary rehabilitation will maintain long-term benefits.
This study concerns patients with a diagnosis of one or more chronic respiratory diseases.
It is a multicenter, blinded, randomized controlled superiority trial in 2 parallel arms:
* a group comparing follow-up and personalized support after a pulmonary rehabilitation program (experimental group)
* a control group receiving only usual care
Eligibility
Primary outcome measure(s)
- Difference in average number of daily steps — At inclusion (V1) and at 24 Months (V5)
The difference in average daily steps measured by accelerometry (over 7 days) at the end of the pulmonary rehabilitation course (V1) and after 24 months of personalized follow-up (V5).
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| CHU de Brest | Brest | France | Recruiting |
| CH des Pays de Morlaix | Morlaix | France | Recruiting |
More University Hospital, Brest trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06579612 on ClinicalTrials.gov ↗ ← All trials in France